Why is Cohance Life falling/rising?

As of 17-Jul, Cohance Lifesciences Ltd is experiencing a price increase, currently at 1,120.00, reflecting a rise of 58.5 (5.51%). The stock has shown strong performance recently, gaining 14.23% over the last seven days and outperforming its sector by 5.09% today. It has generated a return of 29.77% over the past year, significantly higher than the market's return of 1.91%. However, the stock's performance is tempered by some negative indicators, including a decline in PAT for the latest quarter and a poor long-term growth outlook, with operating profit decreasing at an annual rate of -3.76% over the last five years. The company also has a high Price to Book Value ratio, indicating it may be trading at a premium compared to its peers. In the broader market context, the stock's short-term return of +12.31% over the past week contrasts sharply with the Sensex, which has declined by -1.12% during the same period. This suggests that while the stock is gaining traction, it is doing so in a challenging market environment. Despite the recent gains, the stock's long-term growth concerns and declining profitability metrics may weigh on investor sentiment moving forward. The liquidity of the stock remains adequate, but a decrease in delivery volume indicates a potential decline in investor participation, which could impact future price movements.